206
Views
3
CrossRef citations to date
0
Altmetric
Articles

Strategies commercially-insured families use to manage the cost of asthma care: a qualitative interview study

, PhDORCID Icon, , MA, , BS, , MA & , MD, MPHORCID Icon
Pages 96-104 | Received 19 Jul 2021, Accepted 13 Jan 2022, Published online: 24 Jan 2022

References

  • Carrier E, Cunningham P. Medical cost burdens among nonelderly adults with asthma. Am J Manag Care. 2014;20(11):21–2021. [accessed June] https://www.ajmc.com/view/medical-cost-burdens-among-nonelderly-adults-with-asthma
  • Nurmagambetov T, Kuwahara R, Garbe P. The economic burden of asthma in the United States, 2008–2013. Ann Am Thorac Soc. 2018;15(3):348–356. doi:10.1513/AnnalsATS.201703-259OC.
  • Perry R, Braileanu G, Palmer T, Stevens P. The economic burden of pediatric asthma in the United States: literature review of current evidence. Pharmacoeconomics. 2019;37(2):155–167. doi:10.1007/s40273-018-0726-2.
  • Fung V, Graetz I, Galbraith A, Hamity C, Huang J, Vollmer WM, Hsu J, Wu AC. Financial barriers to care among low-income children with asthma: health care reform implications. JAMA Pediatr. 2014;168(7):649–656. doi:10.1001/jamapediatrics.2014.79.
  • Karaca-Mandic P, Jena AB, Joyce GF, Goldman DP. Out-of-pocket medication costs and use of medications and health care services among children with asthma. JAMA. 2012;307(12):1284–1291. doi:10.1001/jama.2012.340.
  • Campbell JD, Allen-Ramey F, Sajjan SG, Maiese EM, Sullivan SD. Increasing pharmaceutical copayments: impact on asthma medication utilization and outcomes. Am J Manag Care. 2011;17(10):703–710.
  • Galbraith AA, Ross-Degnan D, Zhang F, Wu AC, Sinaiko A, Peltz A, Xu X, Wallace J, Wharam JF. Controller medication use and exacerbations for children and adults with asthma in high-deductible health plans. JAMA Pediatr. 2021;175(8):807. doi:10.1001/jamapediatrics.2021.0747.
  • Galbraith AA, Ross-Degnan D, Zhang F, Wu AC, Sinaiko A, LeCates RF, Wallace J, Peltz A, Frank Wharam J. Association of controller use and exacerbations for high-deductible plan enrollees with and without family members with asthma. Ann Am Thorac Soc. 2021;18(7):1255–1260. doi:10.1513/AnnalsATS.202008-1084RL.
  • Goldman DP, Joyce GF, Escarce JJ, Pace JE, Solomon MD, Laouri M, Landsman PB, Teutsch SM. Pharmacy benefits and the use of drugs by the chronically ill. JAMA. 2004;291(19):2344–2350. doi:10.1001/jama.291.19.2344.
  • Ungar WJ, Paterson JM, Gomes T, Bikangaga P, Gold M, To T, Kozyrskyj AL. Relationship of asthma management, socioeconomic status, and medication insurance characteristics to exacerbation frequency in children with asthma. Ann Allergy Asthma Immunol. 2011;106(1):17–23. doi:10.1016/j.anai.2010.10.006.
  • Agarwal R, Gupta A, Fendrick AM. Value-based insurance design improves medication adherence without an increase in total health care spending. Health Aff (Millwood)). 2018;37(7):1057–1064. doi:10.1377/hlthaff.2017.1633.
  • Ross-Degnan D, Wallace J, Zhang F, Soumerai SB, Garabedian L, Wharam JF. Reduced cost-sharing for preventive drugs preferentially benefits low-income patients with diabetes in high deductible health plans with health savings accounts. Med Care. 2020;58:S4–S13. https://journals.lww.com/lww-medicalcare/Fulltext/2020/06001/Reduced_Cost_sharing_for_Preventive_Drugs.4.aspx
  • Gilkey M, Cripps LA, Gruver RS, Washington DV, Galbraith AA. Preventive drug lists as tools for managing asthma medication costs. AJMC. 2020;26(2):75–79. [accessed 2021 June 21]. https://www.ajmc.com/view/preventive-drug-lists-as-tools-for-managing-asthma-medication-costs
  • McDermott C. Financial toxicity: a common but rarely discussed treatment side effect. Ann Am Thorac Soc. 2017;14(12):1750–1752. doi:10.1513/AnnalsATS.201707-578OR.
  • Saunders B, Sim J, Kingstone T, Baker S, Waterfield J, Bartlam B, Burroughs H, Jinks C. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant. 2018;52(4):1893–1907. doi:10.1007/s11135-017-0574-8.
  • Patton MQ. Qualitative research & evaluation methods: integrating theory and practice. Thousand Oaks (CA): Sage Publishing; 2014. [accessed 2021 June 21]. https://us.sagepub.com/en-us/nam/qualitative-research-evaluation-methods/book232962
  • Bloom CI, Douglas I, Olney J, D’Ancona G, Smeeth L, Quint JK. Cost saving of switching to equivalent inhalers and its effect on health outcomes. Thorax. 2019;74(11):1078–1086. doi:10.1136/thoraxjnl-2018-212957.
  • Daubresse M, Andersen M, Riggs KR, Alexander GC. Effect of prescription drug coupons on statin utilization and expenditures: a retrospective cohort study. Pharmacotherapy. 2017;37(1):12–24. doi:10.1002/phar.1802.
  • Starner CI, Alexander GC, Bowen K, Qiu Y, Wickersham PJ, Gleason PP. Specialty drug coupons lower out-of-pocket costs and may improve adherence at the risk of increasing premiums. Health Aff (Millwood)). 2014;33(10):1761–1769. doi:10.1377/hlthaff.2014.0497.
  • Hunter WG, Zhang CZ, Hesson A, Davis JK, Kirby C, Williamson LD, Barnett JA, Ubel PA. What strategies do physicians and patients discuss to reduce out-of-pocket costs? Analysis of cost-saving strategies in 1,755 outpatient clinic visits. Med Decis Making. 2016;36(7):900–910. doi:10.1177/0272989X15626384.
  • Gusmano MK, Maschke KJ, Solomon MZ. Patient-centered care, yes; Patients as consumers, no. Health Aff (Millwood)). 2019;38(3):368–373. doi:10.1377/hlthaff.2018.05019.
  • Cliff BQ, Krenz C, West BT. Attitudes about consumer strategies among Americans in high-deductible health plans. Med Care. 2019;57(3):187–193. https://journals.lww.com/lww-medicalcare/Fulltext/2019/03000/Attitudes_About_Consumer_Strategies_Among.3.aspx
  • Kullgren JT, Cliff BQ, Krenz CD, Levy H, West B, Fendrick AM, So J, Fagerlin A. A survey Of Americans with high-deductible health plans identifies opportunities to enhance consumer behaviors. Health Aff (Millwood). 2019;38(3):416–424. doi:10.1377/hlthaff.2018.05018.
  • Lieu TA, Solomon JL, Sabin JE, Kullgren JT, Hinrichsen VL, Galbraith AA. Consumer awareness and strategies among families with high-deductible health plans. J Gen Intern Med. 2010;25(3):249–254. doi:10.1007/s11606-009-1184-5.
  • Semigran HL, Gourevitch R, Sinaiko AD, Cowling D, Mehrotra A. Patients’ views on price shopping and price transparency. Am J Manag Care. 2017;23(6):e186–e192. [accessed 2021 July 6]. https://www.ajmc.com/view/patients-views-on-price-shopping-and-price-transparency
  • Nguyen E, Weeda ER, Sobieraj DM, Bookhart BK, Piech CT, Coleman CI. Impact of non-medical switching on clinical and economic outcomes, resource utilization and medication-taking behavior: a systematic literature review. Curr Med Res Opin. 2016;32(7):1281–1290. doi:10.1185/03007995.2016.1170673.
  • National Center for Health Statistics. Data Brief 333. Strategies used by adults aged 18–64 to reduce their prescription drug costs. 2017. https://www.cdc.gov/nchs/data/databriefs/db333_tables-508.pdf.
  • Davis SR, Tudball J, Flynn A, Lembke K, Zwar N, Reddel HK. “You’ve got to breathe, you know” – asthma patients and carers’ perceptions around purchase and use of asthma preventer medicines. Aust N Z J Public Health. 2019;43(3):207–213. doi:10.1111/1753-6405.12865.
  • Patel MR, Caldwell CH, Id-Deen E, Clark NM. Experiences addressing health-related financial challenges with disease management among African American women with asthma. J Asthma. 2014;51(5):467–473. doi:10.3109/02770903.2014.885040.
  • Gaffney AW, Hawks L, Bor D, White AC, Woolhandler S, McCormick D, Himmelstein DU. National trends and disparities in health care access and coverage among adults with asthma and COPD: 1997-2018. CHEST. 2021;159(6):2173–2182. doi:10.1016/j.chest.2021.01.035.
  • Stevens D, Sharma K, Kesten S. Insurance status and patient behavior with asthma medications. J Asthma. 2003;40(7):789–793. doi:10.1081/JAS-120023570.
  • Babiarz P, Widdows R, Yilmazer T. Borrowing to cope with adverse health events: liquidity constraints, insurance coverage, and unsecured debt. Health Econ. 2013;22(10):1177–1198. doi:10.1002/hec.2877.
  • Doty MM, Edwards JN, Holmgren AL. Seeing red: Americans driven into debt by medical bills. Results from a National Survey. Issue Brief Commonw Fund. 2005;837:1–12.
  • Brixner D, Mittal M, Rubin DT, Mease P, Liu HH, Davis M, Ganguli A, Fendrick AM. Participation in an innovative patient support program reduces prescription abandonment for adalimumab-treated patients in a commercial population. Patient Prefer Adherence. 2019;13:1545–1556. doi:10.2147/PPA.S215037.
  • Watabayashi K, Steelquist J, Overstreet KA, Leahy A, Bradshaw E, Gallagher KD, Balch AJ, Lobb R, Lavell L, Linden H, et al. A pilot study of a comprehensive financial navigation program in patients with cancer and caregivers. J Natl Compr Canc Netw. 2020;18(10):1366–1373. doi:10.6004/jnccn.2020.7581.
  • Sinaiko AD, Gaye M, Wu AC, Bambury E, Zhang F, Xu X, Wharam JF, Galbraith AA. Out-of-pocket spending for asthma-related care among commercially insured patients, 2004-2016. J Allergy Clin Immunol Pract. 2021;9(12):4324–4331.e7. doi:10.1016/j.jaip.2021.07.054.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.